BIO-BILOBA

Method of administration Oral use. Adults and the Elderly One tablet to be taken twice daily, after food. Tablets should be swallowed whole with a glass of water. 4 'Special warnings and precautions for use') Duration of use If symptoms worsen, or persist for more than 2 weeks, a doctor or qualified healthcare practitioner should be consulted.

Bleeding of individual organs has been reported (eye, nose, cerebral and gastrointestinal haemorrhage). Gastrointestinal disorders such as diarrhoea, abdominal pain, nausea, vomiting; headaches, dizziness and allergic reactions such as erythema, oedema, itching and rash have been reported.

The frequency is not known. If other adverse reactions not mentioned above occur, a doctor or qualified health care practitioner should be consulted. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorization of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store

Do not exceed the stated dose. The use in children and adolescents under 18 years of age has not been established due to lack of adequate data. The product should be discontinued as a precaution 2 weeks prior to surgery since preparations containing Ginkgo might increase susceptibility to bleeding, In patients with epilepsy or taking medicines for epilepsy, onset of further seizures – promoted by intake of Ginkgo preparations – cannot be excluded.

In patients with a pathologically increased bleeding tendency (haemorrhagic diatheisis) and concomitant anticoagulant and antiplatelet treatment, the medicinal product should only be used after consultation with a doctor. 5). If the symptoms worsen or persist for more than 2 weeks, a doctor or a qualified healthcare professional should be consulted.

1.